D.E. Shaw & Co Portfolio holdings
D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
ATVI
Activision Blizzard
ATVI
|
+$757M |
| 2 |
Alibaba
BABA
|
+$544M |
| 3 |
Booking.com
BKNG
|
+$475M |
| 4 |
XLNX
Xilinx Inc
XLNX
|
+$377M |
| 5 |
Caterpillar
CAT
|
+$285M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$1.07B |
| 2 |
Amazon
AMZN
|
+$486M |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$443M |
| 4 |
Salesforce
CRM
|
+$363M |
| 5 |
Qualcomm
QCOM
|
+$352M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 14.27% |
| 2 | Consumer Discretionary | 9.91% |
| 3 | Healthcare | 7.11% |
| 4 | Financials | 6.94% |
| 5 | Communication Services | 6.17% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3826
CNA Financial
CNA
$15B
| $599K | ﹤0.01% |
+14,272
| New | +$623K |
|
3827
CALL
Invesco Mortgage Capital
IVR
$769M
| $599K | ﹤0.01% |
19,000
| – | – |
|
3828
Everspin Technologies
MRAM
$328M
| $599K | ﹤0.01% |
92,409
+64,735
| +234% | +$397K |
|
3829
StoneX
SNEX
$8.99B
| $598K | ﹤0.01% |
45,952
+71
| +0.2% | +$913 |
|
|
TRIL
3830
DELISTED
Trillium Therapeutics Inc.
TRIL
| $597K | ﹤0.01% |
34,014
-23,022
| -40% | -$269K |
|
3831
SunPower Inc
SPWR
$58.3M
| $595K | ﹤0.01% |
61,067
+44,870
| +277% | +$435K |
|
|
VMW
3832
PUT
DELISTED
VMware, Inc
VMW
| $595K | ﹤0.01% |
4,000
| – | – |
|
3833
Quantum Corp
QMCO
$444M
| $594K | ﹤0.01% |
5,731
+196
| +4% | +$23.1K |
|
3834
RE/MAX Holdings
RMAX
$206M
| $592K | ﹤0.01% |
18,984
+11,921
| +169% | +$396K |
|
3835
CALL
Colgate-Palmolive
CL
$74.2B
| $590K | ﹤0.01% |
+7,800
| New | +$619K |
|
|
STR
3836
DELISTED
Sitio Royalties
STR
| $590K | ﹤0.01% |
31,357
-19,132
| -38% | -$357K |
|
|
BRSP
3837
BrightSpire Capital
BRSP
$683M
| $589K | ﹤0.01% |
+62,757
| New | +$607K |
|
3838
PUT
Ross Stores
ROST
$80.5B
| $588K | ﹤0.01% |
+5,400
| New | +$647K |
|
|
SPTN
3839
DELISTED
SpartanNash
SPTN
| $588K | ﹤0.01% |
+26,868
| New | +$540K |
|
3840
Enanta Pharmaceuticals
ENTA
$367M
| $587K | ﹤0.01% |
10,336
-14,404
| -58% | -$712K |
|
|
FCRD
3841
DELISTED
First Eagle Alternative Capital BDC, Inc. Common Stock
FCRD
| $586K | ﹤0.01% |
132,901
| – | – |
|
3842
Allogene Therapeutics
ALLO
$573M
| $584K | ﹤0.01% |
22,708
-179,555
| -89% | -$4.26M |
|
|
HUYA
3843
PUT
Huya Inc
HUYA
$561M
| $584K | ﹤0.01% |
70,000
| – | – |
|
3844
Universal Logistics Holdings
ULH
$393M
| $584K | ﹤0.01% |
29,068
+5,663
| +24% | +$122K |
|
3845
Vera Bradley
VRA
$104M
| $583K | ﹤0.01% |
61,917
-44,597
| -42% | -$489K |
|
|
3846
PUT
Colgate-Palmolive
CL
$74.2B
| $582K | ﹤0.01% |
+7,700
| New | +$611K |
|
3847
Zumiez
ZUMZ
$347M
| $582K | ﹤0.01% |
+14,645
| New | +$625K |
|
|
GATO
3848
DELISTED
Gatos Silver, Inc.
GATO
| $582K | ﹤0.01% |
+50,030
| New | +$697K |
|
3849
BlackRock Corporate High Yield Fund
HYT
$1.36B
| $580K | ﹤0.01% |
47,500
| – | – |
|
|
NUVA
3850
DELISTED
NuVasive, Inc.
NUVA
| $580K | ﹤0.01% |
+9,685
| New | +$597K |
|
Similar funds
D.E. Shaw & Co's Q3 2021 Portfolio in Review
As of Q3 2021, D.E. Shaw & Co held 5,618 positions worth $111B, down 4.4% from $116B the previous quarter. Its ten largest holdings account for 9.2% of the portfolio.
D.E. Shaw & Co withdrew a net $8.92B in Q3 2021, closing 695 positions and reducing 1,634 holdings. Its most notable exit was Alexion Pharmaceuticals, an estimated $228M position sold in full.
By sector, the portfolio is most concentrated in Technology at 14% of assets, down from 16% a quarter earlier, followed by Consumer Discretionary and Healthcare.
Against the trend, D.E. Shaw & Co opened a new position in Sea Limited worth $206M.
- D.E. Shaw & Co's largest Q3 2021 buy was Sea Limited: 645,697 shares worth $206M.
- D.E. Shaw & Co added most to Activision Blizzard in Q3 2021, an estimated $757M increase.
- D.E. Shaw & Co's biggest Q3 2021 reduction was Apple, cutting an estimated $1.07B.
- D.E. Shaw & Co fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $228M.
- D.E. Shaw & Co's ten largest holdings make up 9.2% of its $111B portfolio in Q3 2021.
- D.E. Shaw & Co opened 915 new positions and closed 695 in Q3 2021.
- D.E. Shaw & Co's portfolio value fell 4.4% quarter-over-quarter to $111B.
Based on D.E. Shaw & Co's 13F filing for Q3 2021, filed 15 Nov 2021.